Voyageur Pharmaceuticals (CVE:VM) Trading Up 14.7% – Time to Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) was up 14.7% during mid-day trading on Friday . The company traded as high as C$0.20 and last traded at C$0.20. Approximately 485,000 shares changed hands during trading, an increase of 25% from the average daily volume of 389,063 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Stock Up 11.8 %

The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The firm’s fifty day simple moving average is C$0.09 and its 200 day simple moving average is C$0.07. The stock has a market capitalization of C$26.50 million, a price-to-earnings ratio of -19.00 and a beta of 0.32.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Recommended Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.